Drew Ranieri

Stock Analyst at Morgan Stanley

(0)
# 3207
Out of 5,291 analysts
175
Total ratings
32.95%
Success rate
0.40%
Average return
21 Stocks
Name Action Price Target Current % Upside Ratings Updated
Organogenesis Holdin...
Maintains: Equal-Weight
4 6
4.5 33.33% 4 Mar 5, 2025
Globus Medical
Upgrades: Overweight
83 100
72.5 37.93% 12 Dec 2, 2024
Stryker
Upgrades: Overweight
370 445
364.44 22.11% 9 Dec 2, 2024
SI-BONE
Maintains: Overweight
21 19
14.03 35.42% 15 Aug 6, 2024
Integra Lifesciences
Maintains: Underweight
24 27
21.68 24.54% 13 Jul 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
6 8
8.45 -5.33% 12 Jul 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
26 22
20.3 8.37% 16 Jul 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
10 8
11.84 -32.43% 13 Jul 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
19 16
10.18 57.17% 8 Jul 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
75 83
12.51 559.47% 10 Dec 4, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Underweight
10 8
n/a n/a 11 Nov 14, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
42 38
16.96 124.06% 9 Nov 2, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
88 96
63.01 52.36% 10 May 12, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Underweight
28 26
13.95 86.38% 8 May 4, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
290 295
227.36 29.75% 2 Feb 3, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
236 280
137.75 103.27% 5 Jan 6, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
11 5
8.99 -44.38% 6 Nov 10, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
72 70
33.76 107.35% 4 Oct 11, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
62 54
n/a n/a 1 Jul 15, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
325 300
491.6 -38.97% 6 Apr 25, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
130 148
n/a n/a 1 Aug 2, 2021